Cara Therapeutics develops therapeutics to treat human diseases associated with pain and inflammation.Read more
Innocoll is Cara Therapeutics's #1 rival. Innocoll is a Private company that was founded in Newtown Square, Pennsylvania in 1985. Innocoll competes in the Pharmaceuticals field. Innocoll has 50 more employees vs. Cara Therapeutics.
Targa Therapeutics Corp. is perceived as one of Cara Therapeutics's biggest rivals. Targa Therapeutics Corp. was founded in 2002, and is headquartered in San Diego, California. Targa Therapeutics Corp. is in the field. Targa Therapeutics Corp. generates $ less revenue vs. Cara Therapeutics.
September 15, 2021
Cara Therapeutics's revenue is the ranked 1st among it's top 10 competitors. The top 10 competitors average 19.4M. Over the last three quarters, Cara Therapeutics's revenue has decreased by 79.1%. Specifically, in Q1 2021's revenue was $1.9M; in Q4 2020, it was $112.1M; in Q3 2020, it was $9.3M.
No recent acquisitions found related to Cara Therapeutics
Since Cara Therapeutics was founded in 2004, it has participated in 4 rounds of funding. In total Cara Therapeutics has raised $98.0M. Cara Therapeutics' last funding round was on Jan 2014 for a total of $55.0M
No recent investments found related to Cara Therapeutics